Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.

Authors:
Aimaz Afrough Leonard C Alsfeld Denái R Milton Ruby Delgado Uday R Popat Yago Nieto Partow Kebriaei Betul Oran Neeraj Saini Samer Srour Chitra Hosing Faisal H Cheema Sairah Ahmed Elisabet E Manasanch Hans C Lee Gregory P Kaufman Krina K Patel Donna M Weber Robert Z Orlowski Chelsea C Pinnix Bouthaina S Dabaja Sheeba K Thomas Richard E Champlin Elizabeth J Shpall Muzaffar H Qazilbash Qaiser Bashir

Transplant Cell Ther 2022 May 20. Epub 2022 May 20.

Department of Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

Despite remarkable progress in survival with the availability of novel agents, an overwhelming majority of patients with multiple myeloma (MM) have disease that relapses. Allogeneic (allo-) hematopoietic cell transplantation (HCT) is a potentially curative option for a subgroup of patients with high-risk MM. This study assessed the long-term outcome of MM patients who underwent allo-HCT while in first remission as consolidation treatment. Thirty-three patients with newly diagnosed MM who underwent allo-HCT as part of consolidation therapy between 1994 and 2016 were reviewed retrospectively. Of these patients, 70% underwent autologous HCT before allo-HCT. All patients were chemosensitive and achieved at least partial response before proceeding to allo-HCT. Most received nonmyeloablative/reduced-intensity conditioning (88%) and a matched sibling donor graft (85%). Acute graft-versus-host disease (GVHD) and chronic GVHD occurred in 30% and 61% of patients, respectively. The median duration of follow-up was 64.1 months (range, 1.4 to 199.2 months) for all patients and 164.4 months (range, 56.0 to 199.2 months) for survivors. The median progression-free survival (PFS) was 36 months (95% confidence interval (CI), 8.6 to 73.0 months). The median time from treatment to progression was 73.0 months (95% CI, 30.6 months to not reached). The median overall survival (OS) was 131.9 months (95% CI, 38.4 months to not reached). Of all patients, 39% were alive for more than 10 years, with 46% (n = 6) without progression or relapse. The cumulative incidence of relapse was 18% at 1 year, 39% at 5 years, and 46% at 10 years post-allo-HCT. The cumulative incidence of nonrelapse mortality was 3% at 100 days, 18% at 1 year, 21% at 3 years, and 24% at 5 year post-allo-HCT. On multivariable analysis, high-risk cytogenetics were associated with a shorter PFS (hazard ratio [HR], 2.7; 95% CI, 1.01 to 7.21; P = .047) and OS (HR, 4.91; 95% CI, 1.48 to 16.27; P = .009). Achieving complete remission after allo-HCT also was associated with longer PFS (HR, 0.24; 95% CI, 0.09 to 0.64; P = .004) and OS (HR, .23; 95% CI, .07 to .72; P = .012). Allo-HCT may confer a survival advantage in a selected population of MM patients when performed early in the disease course; additional data on identifying the patients who will benefit the most are needed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtct.2022.05.023DOI Listing
May 2022

Publication Analysis

Top Keywords

patients
12
months 95%
12
months
10
newly diagnosed
8
months range
8
patients newly
8
1992 months
8
cell transplantation
8
underwent allo-hct
8
hematopoietic cell
8
730 months
8
months reached
8
years 46%
8
cumulative incidence
8
18% year
8
multiple myeloma
8
95%
7
allo-hct
6
641 months
4
years
4

Keyword Occurance

Similar Publications

Staffing crisis capacity: a different approach to healthcare resource allocation for a different type of scarce resource.

Authors:
Catherine R Butler Laura B Webster Douglas S Diekema

J Med Ethics 2022 Jul 1. Epub 2022 Jul 1.

Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.

Severe staffing shortages have emerged as a prominent threat to maintaining usual standards of care during the COVID-2019 pandemic. In dire settings of crisis capacity, healthcare systems assume the ethical duty to maximise aggregate population-level benefit of existing resources. To this end, existing plans for rationing mechanical ventilators and intensive care unit beds in crisis capacity focus on selecting individual patients who are most likely to survive and prioritising these patients to receive scarce resources. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Clinical utility of serum tryptase levels in pediatric anaphylaxis.

Authors:
Zeynep Sengul Emeksiz Deniz Yılmaz Basak Alan Secil Doga Tunc Emine Dibek Mısırlıoglu

Allergy Asthma Proc 2022 Jul 1. Epub 2022 Jul 1.

Introduction: This study aimed to evaluate the preliminary diagnosis, demographic characteristics, and outcomes of patients whose serum total tryptase levels were measured while in a tertiary pediatric hospital and to ascertain the role of serum tryptase levels in the etiology, diagnosis, severity, and course of systemic anaphylaxis.

Methods: Patients ages between 1 month and 17 years who were followed up in the pediatric emergency department or as inpatients and with a diagnosis of immediate-type reactions between September 1, 2019, and August 31, 2021, were includedin the study. Patient data were obtained retrospectively by examination of medical records and patient observation forms. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Meeting the Challenges of COVID-19: Evaluation of Nurse-Led Changes to Telephonic Assessment.

Authors:
Barbara Squeri Matthew Gayton Jennifer Huang Silvia Chavez Kimberly Souffront

Home Healthc Now 2022 Jul-Aug 01;40(4):214-222

The early months of the COVID-19 pandemic caused suspension of physician home visits at our NYC home-based primary care practice as well as disruptions in community-based services homebound patients rely on. This produced gaps in care for a vulnerable patient population that is considered underserved and medically and socially complex. Telephone triage nurses at Mount Sinai Visiting Doctors Program responded to these gaps in care with targeted enhancements to telephonic patient assessment: creating an encrypted email address to receive photographs, the use of two Epic dot phrases to screen and educate regarding COVID-19, assessment of patients' ability to complete a video visit, the reassessment of goals of care, and the assessment of changes in home care services. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Establishing a Nurse Champion Education Program for Perinatal Home Health Nurses.

Authors:
Pamela C Smith Catherine F Yonkaitis

Home Healthc Now 2022 Jul-Aug 01;40(4):209-213

Professional development is essential for the ongoing professional growth of nurses and ensures employers and patients that staff have current knowledge in the field. But what happens when there's no budget for professional development? This quality improvement project describes the use of a nurse champion intervention for a professional development program for perinatal home health nurses at a nonprofit health organization. A nurse champion mentors and advocates for nurse colleagues during a change project. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Impact of an extrafascial versus intrafascial injection for supraclavicular brachial plexus block on respiratory function: a randomized, controlled, double-blind trial.

Authors:
Sina Grape Kyle Kirkham Nadjib Zemirline Alexis Bikfalvi Eric Albrecht

Reg Anesth Pain Med 2022 Jul 1. Epub 2022 Jul 1.

University of Lausanne, Lausanne, Switzerland

Introduction: Hemidiaphragmatic paresis after ultrasound-guided supraclavicular brachial plexus block is reported to occur in up to 67% of patients. We tested the hypothesis that an injection outside the brachial plexus sheath reduces the incidence of hemidiaphragmatic paresis compared with an intrafascial injection while providing similar analgesia.

Methods: Fifty American Society of Anesthesiologists I-III patients scheduled for elective upper limb surgery received a supraclavicular brachial plexus block using 30 mL of 1:1 mixture of mepivacaine 1% and ropivacaine 0. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap